Sort   by:  
 Page size 
UnknownHeterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature.
Not available
S-EPMC11960392 | biostudies-literature
UnknownValidation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Not available
S-EPMC10367935 | biostudies-literature
UnknownMonitor-Watcher Use, Nurses' Knowledge of Electrocardiographic Monitoring, and Arrhythmia Detection.
Not available
S-EPMC8246648 | biostudies-literature
UnknownRandomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
Not available
S-EPMC8462593 | biostudies-literature
UnknownRole of neighborhood context in ovarian cancer survival disparities: current research and future directions.
Not available
S-EPMC10538437 | biostudies-literature
UnknownReal-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Not available
S-EPMC8384401 | biostudies-literature
UnknownDevelopment and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Not available
S-EPMC9905474 | biostudies-literature
UnknownPrimary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.
Not available
S-EPMC3434981 | biostudies-literature
UnknownAsian American Enclaves and Healthcare Accessibility: An Ecologic Study Across Five States.
Not available
S-EPMC10921977 | biostudies-literature
UnknownOutcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
Not available
S-EPMC7050154 | biostudies-literature
Sort   by:  
 Page size